Alpha Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$820K Sell
684
-3
-0.4% -$3.06K 0.43% 36
2026
Q1
$632K Buy
687
+76
+12% +$77K 0.37% 40
2025
Q4
$656K Buy
611
+151
+33% +$144K 0.4% 38
2025
Q3
$351K Sell
460
-33
-7% -$24.6K 0.23% 61
2025
Q2
$384K Hold
493
0.28% 54
2025
Q1
$407K Buy
493
+37
+8% +$30.8K 0.33% 41
2024
Q4
$352K Buy
456
+211
+86% +$175K 0.28% 45
2024
Q3
$217K Sell
245
-212
-46% -$191K 0.15% 103
2024
Q2
$414K Sell
457
-8
-2% -$6.4K 0.36% 38
2024
Q1
$362K Hold
465
0.33% 39
2023
Q4
$271K Sell
465
-4
-0.9% -$2.33K 0.27% 51
2023
Q3
$252K Sell
469
-200
-30% -$103K 0.29% 63
2023
Q2
$314K Hold
669
0.33% 59
2023
Q1
$230K Hold
669
0.26% 85
2022
Q4
$245K Buy
+669
New +$237K 0.3% 69

Other funds holding LLY

Alpha Financial Partners's LLY Position: Q2 2026 in Review

Alpha Financial Partners reduced its Eli Lilly (LLY) stake by 0.44% in Q2 2026, selling an estimated $3.06K and leaving 684 shares worth $820K. The position accounts for 0.43% of the portfolio, ranked #36.

Alpha Financial Partners first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alpha Financial Partners held 684 shares of Eli Lilly worth $820K as of Q2 2026.
  • Alpha Financial Partners sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.43% of Alpha Financial Partners's portfolio in Q2 2026, its #36 holding.
  • Alpha Financial Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alpha Financial Partners's 13F filing for Q2 2026, filed 11 Aug 2026.